TY - JOUR
T1 - The out-of-pocket expenses of people with tinnitus in Europe
AU - Jarach, Carlotta M
AU - Karydou, Kyriaki
AU - Trochidis, Ilias
AU - Bernal-Robledano, Alberto
AU - van den Brandt, Piet A
AU - Cima, Rilana
AU - Cederroth, Christopher R
AU - Lopez-Escamez, Jose Antonio
AU - Ghislandi, Simone
AU - Hall, Deborah Ann
AU - Kikidis, Dimitris
AU - Langguth, Berthold
AU - Lugo, Alessandra
AU - Mazurek, Birgit
AU - Odone, Anna
AU - Schecklmann, Martin
AU - Schoisswohl, Stefan
AU - Simoes, Jorge
AU - Schlee, Winfried
AU - Gallus, Silvano
PY - 2024/11/5
Y1 - 2024/11/5
N2 - BACKGROUND: Despite the high frequency of tinnitus and its impact on wellbeing, little is known about its economic burden, and, to our knowledge, no data are available on out-of-pocket (OOP) expenses. METHODS: In 2022, a survey was conducted on OOP costs of tinnitus. We enrolled 679 participants with slight, moderate, and severe tinnitus in Italy, United Kingdom, Netherlands, Germany, and Spain. We estimated annual OOP expenses for tinnitus-related healthcare visits, treatments, medications, and alternative medicine practices. Prevalence of tinnitus in the general population, obtained from a representative survey we conducted in Europe in 2017-2018, was used to generalize costs for people with any tinnitus at the national level. RESULTS: OOP expenses were 368€ (95% confidence intervals [CI], 78€-690€), 728€ (95% CI, 316€-1,288€), and 1,492€ (95% CI, 760€-2,688€) for slight, moderate, and severe tinnitus, respectively, with annual expenditure of 565€ for people with any tinnitus: 209€ for healthcare visits; 93€ for treatments; 16€ for drugs; 64€ for hearing supporting systems; and 183€ for acupuncture, homeopathy, and osteopathy. Individuals with slight, moderate, and severe tinnitus expressed a willingness to invest 1.6, 4.3, and 7.0 times their monthly income, respectively, to achieve complete relief from tinnitus. CONCLUSION: This study offers for the first time insights into the OOP expenses incurred by individuals with tinnitus. OOP expenses exhibited substantial variations based on severity status, accounting for more than 17 billion € in the countries considered. In terms of financial burden, these findings align tinnitus to the recognized leading disabilities, including back pain and migraine.
AB - BACKGROUND: Despite the high frequency of tinnitus and its impact on wellbeing, little is known about its economic burden, and, to our knowledge, no data are available on out-of-pocket (OOP) expenses. METHODS: In 2022, a survey was conducted on OOP costs of tinnitus. We enrolled 679 participants with slight, moderate, and severe tinnitus in Italy, United Kingdom, Netherlands, Germany, and Spain. We estimated annual OOP expenses for tinnitus-related healthcare visits, treatments, medications, and alternative medicine practices. Prevalence of tinnitus in the general population, obtained from a representative survey we conducted in Europe in 2017-2018, was used to generalize costs for people with any tinnitus at the national level. RESULTS: OOP expenses were 368€ (95% confidence intervals [CI], 78€-690€), 728€ (95% CI, 316€-1,288€), and 1,492€ (95% CI, 760€-2,688€) for slight, moderate, and severe tinnitus, respectively, with annual expenditure of 565€ for people with any tinnitus: 209€ for healthcare visits; 93€ for treatments; 16€ for drugs; 64€ for hearing supporting systems; and 183€ for acupuncture, homeopathy, and osteopathy. Individuals with slight, moderate, and severe tinnitus expressed a willingness to invest 1.6, 4.3, and 7.0 times their monthly income, respectively, to achieve complete relief from tinnitus. CONCLUSION: This study offers for the first time insights into the OOP expenses incurred by individuals with tinnitus. OOP expenses exhibited substantial variations based on severity status, accounting for more than 17 billion € in the countries considered. In terms of financial burden, these findings align tinnitus to the recognized leading disabilities, including back pain and migraine.
KW - Tinnitus
KW - economic burden
KW - epidemiology
KW - out of pocket costs
KW - patients’ perspective
U2 - 10.2188/jea.JE20230358
DO - 10.2188/jea.JE20230358
M3 - Article
SN - 1349-9092
VL - 34
SP - 515
EP - 525
JO - Journal of epidemiology
JF - Journal of epidemiology
IS - 11
ER -